Levolta is developing custom formulations of pharmaceutical products that currently generate unwanted side effects. One of the most frequently prescribed intravenous drugs for treating rheumatoid arthritis, zoledronic acid, often creates severe flu-like symptoms and other complications in patients. Through a proprietary reformulation of an existing product, Levolta has achieved comparable therapeutic results for patients while greatly reducing negative side effects. Several other drugs are also in reformulation.